HealthEquity, Inc. (HQY) स्टॉक विश्लेषण

कंपनी का अवलोकन

HealthEquity, Inc. operates within the healthcare sector, specifically serving the health information services industry by providing technology-enabled services platforms to consumers and employers across the United States. The company offers a range of financial tools including health savings accounts, an investment platform, and online-only automated investment advisory services delivered through its Web-based tool, Advisor. This entity demonstrates significant scale with a total market capitalization of $7.19B and generates annual revenue of $1.31B based on trailing twelve-month figures. The organization employs a workforce of 2,814 individuals to support its operations, indicating a substantial organizational footprint. The market cap figure suggests that the market values the company at a premium relative to its tangible book value, while the revenue magnitude positions it as a major player in the health information services landscape.

वित्तीय स्वास्थ्य

The company reported revenue of $1.31B and a net income of $215.20M for the trailing twelve months, with an EBITDA of $482.14M. The gap between the total revenue of $1.31B and the net income of $215.20M reveals a cost structure where operating expenses, including cost of goods sold and general administrative costs, consume a significant portion of top-line earnings before arriving at the bottom line. The business generated free cash flow of $338.05M, which indicates strong financial flexibility allowing the firm to fund operations, invest in technology, or manage debt obligations without immediate external financing needs. Profitability analysis shows a gross margin of 69.5%, an operating margin of 21.6%, and a profit margin of 16.4%, where the high gross margin reflects the capital-light, technology-driven nature of the service platform, while the operating and profit margins demonstrate effective cost management relative to sales volume. Regarding liquidity and leverage, the company holds $318.93M in cash against $1.00B in total debt, resulting in a debt-to-equity ratio of 47.53%. The current ratio stands at 3.27, which signifies a highly conservative balance sheet with ample short-term assets to cover short-term liabilities comfortably. Return on Equity is recorded at 10.2% and Return on Assets at 6.0%, metrics that reveal management's effectiveness in generating shareholder value relative to equity invested and utilizing the total asset base to produce earnings.

मूल्यांकन आकलन

Valuation metrics indicate a trailing P/E ratio of 34.23 and a forward P/E of 15.76, implying that the market expects a substantial acceleration in earnings growth to justify the current high multiple compared to the forward estimate. The price-to-book ratio is 3.40, suggesting that the stock trades at a significant premium over its book value, reflecting investor confidence in the company's intangible assets and future growth potential. Alternative valuation measures include a price-to-sales ratio of 5.48 and an EV/EBITDA of 16.17, which provide context on how the market prices revenue and earnings quality independent of historical earnings per share. The stock has traded between a 52-week low of $72.76 and a 52-week high of $116.65, meaning the current price sits below the recent peak but remains well above the yearly floor. The beta value is 0.26, indicating that the stock exhibits low price volatility and is less sensitive to broader market movements compared to the general equity market index.

Growth & Income

Revenue growth stands at 7.3% year-over-year while earnings growth reaches 92.4% year-over-year, indicating that earnings are expanding at a rate far exceeding revenue growth, likely due to operational leverage and efficiency improvements. The company does not currently pay dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%. Consequently, the firm reinvests all of its net income back into the business to fund technology development and expansion rather than distributing cash to shareholders. The overall growth and income profile is characterized by robust earnings expansion driven by internal growth factors rather than shareholder payouts, supported by a strong balance sheet that allows for continued investment in the health savings account and investment platform ecosystems.